 |
 |

Imipramine and Desipramine in Plasma and Spinal FluidRelationship to Clinical Response and Serotonin Metabolism
Giovanni Muscettola, MD;
Frederick K. Goodwin, MD;
William Z. Potter, MD;
Magda M. Claeys, PhD;
Sanford P. Markey, PhD
Arch Gen Psychiatry. 1978;35(5):621-625.
Abstract
 |  |
In a double-blind study of depressed patients treated with imipramine hydrochloride, levels of imipramine and desipramine were measured in plasma and in CSF. Levels of both drugs in CSF were approximately 10% of plasma levels, but the levels in the two body fluids were highly correlated. The levels of both drugs were approximately equal in plasma, but desipramine predominated in CSF (imipramine/desipramine ratio of 0.8). The imipramine-induced alteration in CSF levels of the serotonin metabolite (5-hydroxy-indoleacetic acid [5HIAA]) correlated with imipramine levels but not with desipramine. For the group of patients showing a clear antidepressant response, the mean drug levels were nearly double those of the nonresponder group, a difference that did not quite reach statistical significance in this relatively small sample. The desipramine levels showed no responder-nonresponder difference, while the ratio of imipramine/desipramine was significantly higher among the responders. On the average this particular patient group had relatively low pretreatment levels of 5HIAA in CSF, an observation that may partially account for the relatively low overall response rate to imipramine.
Author Affiliations
From the Clinical Psychobiology Branch (Drs Muscettola, Goodwin, and Potter) and the Laboratory of Clinical Science (Drs Claeys and Markey), National Institute of Mental Health, Bethesda, Md. Dr Muscettola is now with the Department of Psychiatry, University of Naples, and Dr Claeys is with the Laboratory of Organic Chemistry, RUG, Ghent, Belgium.
Footnotes
Accepted for publication Oct 18, 1977.
Reprint requests to Clinical Psychobiology Branch, Bldg 10, Room 4S239, National Institutes of Mental Health, Bethesda, MD 20014 (Dr Goodwin).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
The Mechanism of Activity-Dependent Sodium Channel Inhibition by the Antidepressants Fluoxetine and Desipramine
Lenkey et al.
Mol. Pharmacol. 2006;70:2052-2063.
ABSTRACT
| FULL TEXT
Inhibition of Norepinephrine Uptake in Patients With Major Depression Treated With Paroxetine
Gilmor et al.
Am. J. Psychiatry 2002;159:1702-1710.
ABSTRACT
| FULL TEXT
Role of High-Affinity Receptors and Membrane Transporters in Nonsynaptic Communication and Drug Action in the Central Nervous System
Vizi
Pharmacol. Rev. 2000;52:63-90.
ABSTRACT
| FULL TEXT
Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure Homework
Marks et al.
Arch Gen Psychiatry 1983;40:153-162.
ABSTRACT
Clomipramine Treatment of Obsessive-Compulsive Disorder: II. Biochemical Aspects
Thoran et al.
Arch Gen Psychiatry 1980;37:1289-1294.
ABSTRACT
Effects of a Dopamine Agonist Piribedil in Depressed Patients: Relationship of Pretreatment Homovanillic Acid to Antidepressant Response
Post et al.
Arch Gen Psychiatry 1978;35:609-615.
ABSTRACT
|